Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
537.00    12.00 (2.29%)
Bid:
531.00
Ask:
537.00
Spread: 6.00 (1.13%)
Market Cap: £309.01m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

Trading Update

24 Jul 2025 07:00

RNS Number : 2975S
Mortgage Advice Bureau (Hldgs) PLC
24 July 2025
 

24 July 2025

Mortgage Advice Bureau (Holdings) plc

("MAB" or the "Group")

 

Trading Update

 

Mortgage Advice Bureau (Holdings) plc (AIM: MAB1.L), a leading technology-driven UK mortgage network and broker, today issues a trading update for the six months ended 30 June 2025, ahead of publishing its interim results on 23 September 2025.

 

Group revenue for the six months ended 30 June 2025 increased by 19% to c.£147m (H1 2024: £123.9m) and the Board expects to report Adjusted PBT of c.£14m, representing 14% growth on the equivalent period last year (2024: £12.3m).

 

MAB delivered a solid performance in H1 2025, with gross mortgage completions1 increasing by 14% to c.£13.8bn (H1 2024: £12.1bn), supported in part by the timing effect of property transactions brought forward ahead of the 31 March 2025 changes to Stamp Duty Land Tax (SDLT) relief. We are pleased that MAB's market share of new mortgage lending1 increased to 8.3% for the five months to May 31 2025 (2024: 8.1%).

 

The number of mainstream advisers2 at 30 June 2025 was up 5% on the prior year end to 2,041 (31 December: 1,941). Average revenue per mainstream adviser for the first half increased by 14% to £74k (H1 2024: £65k).

 

Current trading and Outlook

The Group continues to trade in line with the Board's expectations.

 

We see continued indications of a gradual recovery in underlying purchase activity, supported by buyer affordability and an increase in supply of new properties coming on market. Looking ahead, refinancing is expected to accelerate in the second half of 2025 and into 2026, as a substantial volume of 5-year fixed mortgages from the post-pandemic boom and 2-year fixed deals taken out following the 2022 mini budget approach maturity.

 

We welcome the Financial Conduct Authority's (FCA's) initiatives to promote responsible lending (most notably through fairer affordability testing and lower deposit requirements) and to simplify a number of existing mortgage rules. These initiatives, including the 'Policy Statement on Mortgage Rule Review', should enable more renters to become first-time buyers and make refinancing more accessible and straightforward.

 

 

Peter Brodnicki, Founder and CEO of MAB, commented:

"I am pleased to report a strong performance in the first half of 2025 with the mortgage market showing signs of a sustainable recovery. Adviser productivity is continuing to increase, and strong momentum is building in adviser growth.

 

It is encouraging to see the Government so focused on housebuilding and home ownership initiatives, and we are already seeing an immediate and positive response from the financial regulators, providing a supportive backdrop for the housing and mortgage market."

 

[1] Based on first charge mortgage completions, secured personal loans (second charge mortgages), later life lending mortgages and bridging finance. Gross mortgage lending includes Product Transfers. New mortgage lending excludes Product Transfers.

 

2 Excludes directly authorised advisers, later life advisers without a mortgage and protection license, and advisers in the process of being onboarded who are not yet able to trade. Also includes 23 advisers from our investment in Mortgage Mum, who are currently being onboarded under MAB's AR arrangements.

 

 

Enquiries:

Mortgage Advice Bureau (Holdings) plc

Via Camarco

 

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Deputy Chief Executive Officer

Emilie McCarthy, Chief Financial Officer 

 

 

Nominated Adviser and Joint Broker

Keefe, Bruyette & Woods, a Stifel Company

Erik Anderson / Nick Harland / Francis North

 

 

+44 (0) 20 7710 7600

Joint Broker

Berenberg

James Felix / Michael Burke / Dan Gee-Summons 

 

 

+44 (0) 20 3207 7800

Joint Broker

Peel Hunt LLP

Andrew Buchanan / Oliver Jackson / Rob Parker

 

+44 (0) 20 7418 8900

Media Enquiries

Camarco

Tom Huddart / Letaba Rimell

 

 

mab@camarco.co.uk

Investor Relations

 

Investor.relations@mab.org.uk

About MAB:

MAB is one of the UK's leading consumer intermediary brands and specialist networks for mortgage advisers. 

Through its partner firms known as Appointed Representatives (ARs), MAB has approximately 2,000 advisers providing expert advice to customers on a range of mortgage, specialist lending, protection, and general insurance products. MAB supports its AR firms with proprietary technology and services, including adviser recruitment and lead generation, learning and development, compliance auditing and supervision, and digital marketing and website solutions.

For more information, visit www.mortgageadvicebureau.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSEDAIVFIE
Date   Source Headline
13th Jun 20234:39 pmRNSTR-1: Notification of major holdings
1st Jun 202311:52 amRNSDirector/PDMR Shareholding
24th May 20235:16 pmRNSResult of AGM
24th May 20237:00 amRNSAGM Statement
16th May 20232:23 pmRNSPDMR Dealing and Total Voting Rights
28th Apr 20231:53 pmRNSDirectors' Shareholdings and PDMR notification
27th Apr 20234:39 pmRNSNotification of major holdings
20th Apr 20234:29 pmRNSPosting of Report and Accounts and Notice of AGM
17th Apr 20235:08 pmRNSPDMR dealing and Total Voting Rights
31st Mar 20232:25 pmRNSDirectors' Shareholdings and PDMR notification
28th Mar 20237:00 amRNSFinal Results for the year ended 31 December 2022
14th Mar 20235:05 pmRNSDirectors' Shareholdings and PDMR notification
9th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20233:35 pmRNSNon-Executive Director Board change
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20231:54 pmRNSDirectors' Shareholdings and PDMR notification
24th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20235:06 pmRNSDirectors' Shareholdings and PDMR notification
2nd Feb 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20234:29 pmRNSDirectors' Shareholdings and PDMR notification
31st Jan 20237:00 amRNSTrading Update
17th Jan 20234:07 pmRNSDirectors' Shareholdings and PDMR notification
3rd Jan 20239:54 amRNSDirector's Shareholdings and PDMR notification
21st Dec 20227:00 amRNSAppointment of Joint Broker
14th Dec 20224:40 pmRNSSecond Price Monitoring Extn
14th Dec 20224:35 pmRNSPrice Monitoring Extension
14th Dec 20221:51 pmRNSDirectors' Shareholdings and PDMR notification
1st Dec 20227:00 amRNSTrading Update
30th Nov 20224:50 pmRNSDirectors' Shareholdings and PDMR notification
14th Nov 20224:15 pmRNSPDMR dealing notification and Total Voting Rights
7th Nov 20225:01 pmRNSDirectors' Shareholdings and PDMR notification
31st Oct 20221:18 pmRNSDirectors' Shareholdings and PDMR notification
14th Oct 20225:04 pmRNSDirectors' Shareholdings and PDMR notification
6th Oct 20225:16 pmRNSHolding(s) in Company
6th Oct 20227:00 amRNSDirectors' Shareholdings and PDMR notification
4th Oct 20224:27 pmRNSHolding(s) in Company
3rd Oct 20225:13 pmRNSTotal Voting Rights
3rd Oct 20225:11 pmRNSHolding(s) in Company
30th Sep 202210:21 amRNSDirectors' Shareholdings and PDMR notification
27th Sep 20227:00 amRNSInterim Results
16th Sep 202210:36 amRNSDirectors' Shareholdings and PDMR notification
31st Aug 202212:53 pmRNSDirectors' Shareholdings and PDMR notification
16th Aug 202210:27 amRNSDirector/PDMR Shareholding
8th Aug 20224:36 pmRNSDirectors' Shareholdings and PDMR notification
29th Jul 20221:03 pmRNSPDMR dealing notification and Total Voting Rights
28th Jul 20224:40 pmRNSSecond Price Monitoring Extn
28th Jul 20224:35 pmRNSPrice Monitoring Extension
28th Jul 20227:00 amRNSTrading Update
14th Jul 20225:31 pmRNSDirector/PDMR Shareholding
14th Jul 20224:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.